Hologic Announces Financial Results for First Quarter of Fiscal 2018
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Hologic (HOLX) PT Lowered to $48 at Canaccord Genuity Following 1Q Results
February 12, 2018 7:54 AM ESTCanaccord Genuity lowered its price target on Hologic (NASDAQ: HOLX) to $48.00 (from $50.00) while maintaining a Buy rating following the company's 1Q results. Revenues of ~$791M beat the Street's $786M, and adjusted EPS of $0.55 beat the Street's $0.50.
HOLX reiterated its prior FY'18... More
